In 2023, the average length of stay (ALOS) for dermatitis, eczema, and papulosquamous disorders cases in UK hospitals was 4.8 days. From 2024, forecasted data indicate a progressive decline in ALOS: 4.7 days in 2024, reducing to 4.1 days by 2028. Year-on-year percentage changes show a consistent decrease, with a compound annual growth rate (CAGR) of -3.76% over the five-year span.

Future trends to watch for include:

Advancements in outpatient care and telemedicine reducing hospital stay lengths further.
Introduction of new treatment protocols that may influence admission or discharge processes.
Policy changes in healthcare that focus on reducing hospital loads and enhancing community care.